Chemist + Druggist is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Jeremy Meader to replace John D’Arcy as Numark managing director

Phoenix sales director Jeremy Meader will replace John D’Arcy as managing director of Numark next year.

Mr Meader will take up the position of director on February 1, as Mr D’Arcy retires from the position after a decade with the buying group, it announced today (November 8).

Mr Meader had been sales director at wholesaler Phoenix – which owns Numark – for three years, after working at GlaxoSmithKline and Alliance Healthcare.

Mr D’Arcy will remain an ambassador for the group as a non-executive chairman, Numark said.

Phoenix UK’s group managing director Steve Anderson said: “We have a great team at Numark, and are going from strength to strength with ambitious growth plans over the coming years.”

“Our sector is facing many challenges, but I know Jeremy and John will develop the solutions and support our customers' need to succeed”.

Numark said Mr Meader has a “unique understanding of the Numark membership, having headed up the pharmacy development team”.

Mr D’Arcy is a regular blogger for C+D. Read his latest article – on the 15p increase in advance payments – here.

What has been the most memorable C+D blog by John D'Arcy ?

Related Content


Pharmacy Dispenser/ Technician
Bethnal Green North, London
Salary: Up to £30,000

Apply Now



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts